medigraphic.com
SPANISH

Cirugía de Columna

ISSN 2992-7749 (Electronic)
ISSN 2992-7897 (Print)
Órgano Oficial de difusión científica de la Asociación Mexicana de Cirujanos de Columna A. C. y de la Sociedad Iberolatinoamericana de Columna. SILACO.

Indizada en:

Scielo
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Políticas
    • Objetivos y Alcance
    • Carta de autorización de pacientes
    • Política publicitaria
    • Políticas éticas
    • Políticas de acceso abierto
    • Políticas de revisión de manuscritos
    • Políticas editoriales generales
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 4

<< Back Next >>

Cir Columna 2026; 4 (4)

Intramedullary spinal metastasis: diagnostic and therapeutic challenges in a rare condition. A case report and literature review

Paz-Jaimes OD, Pérez-Carranza S, Aldape-Ocañas FG, Cortés-González PT, González-Gómez MA, Vázquez-Martínez BR
Full text How to cite this article 10.35366/123552

DOI

DOI: 10.35366/123552
URL: https://dx.doi.org/10.35366/123552

Language: Spanish
References: 17
Page: 334-343
PDF size: 1064.67 Kb.


Key words:

intramedullary spinal cord metastases, intramedullary spinal cord neoplasms, malignant spinal cord neoplasms, spinal cord tumor, surgical treatment of intramedullary neoplasms.

ABSTRACT

Intramedullary spinal cord metastases (ISCM) are rare entities, representing approximately 8.5% of central nervous system metastases. They occur in only 0.1-0.4% of cancer patients and account for 1-3% of all intramedullary neoplasms. Lung cancer, particularly small cell carcinoma, is the most frequent primary tumor leading to ISCM (54%), followed by breast cancer (13%). Other less common sources include malignant melanoma, lymphoma, and colorectal cancer. Gastrointestinal tumors rarely metastasize to the spinal cord, more commonly spreading to the liver, lymph nodes, bones, and adrenal glands. Most ISCM cases are diagnosed in patients with a known history of cancer. Diagnosis is primarily based on gadolinium-enhanced magnetic resonance imaging, with T2-weighted sequences providing essential details on lesion location, morphology, and associated edema. Surgical treatment has become a valid option in selected cases due to advances in imaging. It is indicated for patients with a single, well-demarcated lesion, limited systemic metastases, progressive neurological deterioration, and good functional status. The goals of surgery include spinal cord decompression, neurological function preservation or improvement, and histopathological confirmation. Early resection can improve both survival and quality of life, with postoperative survival averaging up to 11.6 months. Encapsulated or cystic tumors favor complete resection, whereas leptomeningeal or infiltrative lesions require partial resection to avoid irreversible neurological damage. Although radiotherapy remains the standard treatment, surgical intervention is increasingly favored due to better functional outcomes and symptom control. Treatment decisions should be individualized based on patient age, tumor type, radiosensitivity, and the potential to enhance quality of life. This report of a patient with an intramedullary metastasis at L1 whose initial symptom was recent-onset lumbosacral pain followed by lower limb weakness (Karnofsky score: 80). Diagnosis was confirmed by gadolinium-enhanced MRI, and surgical resection was performed. Histopathology revealed a metastatic lesion originating from a gastrointestinal adenocarcinoma.


REFERENCES

  1. Grasso G, Meli F, Patti R, Giambartino F, Florena AM, Iacopino DG. Intramedullary spinal cord tumor presenting as the initial manifestation of metastatic colon cancer: case report and review of the literature. Spinal Cord. 2007; 45: 793-796.

  2. Hommadi M, Belemlih M, Marnouch E, Maghous A, Zaghba N, Hamidi FZ, et al. Intramedullary spinal cord metastases: report of three cases and review of the literature. Cancer Radiother. 2021; 25: 169-174. doi: 10.1016/j.canrad.2020.10.003.

  3. Pérez-Suárez J, Barrio-Fernández P, Ibáñez-Plágaro FJ, Ribas-Ariño T, Calvo-Calleja P, Mostaza-Saavedra AL. Metástasis intramedular de adenocarcinoma gástrico: caso clínico y revisión de la literatura. Neurocirugía. 2016; 27: 28-32.

  4. Carvajal F, García R, Rojas F, Sallabanda K. Stereotactic radiosurgery for intramedullary spinal cord metastases: a systematic review and meta-analysis. Cureus. 2025; 17: e80025.

  5. Goncharov YE, Zubatkina IS, Ivanov PI. Stereotactic high-dose irradiation for intramedullary metastases. Zh Vopr Neirokhir Im N N Burdenko. 2024; 88: 22-30.

  6. Hrabalek L. Intramedullary spinal cord metastases: review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154: 117-122.

  7. Kaya S, Lam FC, Stevenson MA, Motiei-Langroudi R, Kasper EM. Intramedullary metastases to conus medullaris: a review of the literature with a case illustration. Brain Sci. 2024; 14: 761.

  8. Gazzeri R, Telera S, Galarza M, Callovini GM, Sperduti I, Alfieri A. Surgical treatment of intramedullary spinal cord metastases: functional outcome and complications—a multicenter study. Neurosurg Rev. 2021; 44: 3267-3275. doi: 10.1007/s10143-021-01491-8.

  9. Quraishi NA, Gokaslan ZL, Boriani S. The surgical management of metastatic epidural compression of the spinal cord. J Bone Joint Surg Br. 2010; 92: 1054-1060. doi: 10.1302/0301-620X.92B8.22296.

  10. Payer S, Mende KC, Westphal M, Eicker SO. Intramedullary spinal cord metastases: an increasingly common diagnosis. Neurosurg Focus. 2015; 39: E15.

  11. Kalayci M, Ca?avi F, Gül S, Yenidünya S, Açikgöz B. Intramedullary spinal cord metastases : diagnosis and treatment —an illustrated review . Acta Neurochir (Wien). 2004; 146(12): 1347-1354. doi:10.1007/s00701-004-0386-1.

  12. Taniura S, Tatebayashi K, Watanabe K, Watanabe T. Intramedullary spinal cord metastasis from gastric cancer: case report. J Neurosurg Spine. 2000; 93: 145-147.

  13. Hashii H, Mizumoto M, Kanemoto A, Harada H, Asakura H, Hashimoto T, et al . Radiotherapy for patients with symptomatic intramedullary spinal cord metastasis. J Radiat Res. 2011; 52 (5): 641-645. doi:10.1269/jrr.10173.

  14. Schiff D, O'Neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology. 1996; 47 (4): 906-912. doi:10.1212/WNL.47.4.906.

  15. Dam -Hieu P, Seizeur R, Mineo JF, Metges JP, Meriot P, Simon H . Retrospective study of 19 patients with intramedullary spinal cord metastasis. Clin Neurol Neurosurg. 2009; 111 (1): 10-17. doi:10.1016/j.clineuro.2008.07.005.

  16. Scalia G, Costanzo R, Viola A, Bonosi L, Porzio M, Giovannini A, et al. Intramedullary spinal cord metastases from breast cancer: a systematic review. Anticancer Res. 2023; 43: 523-535.

  17. Connolly ES Jr, Winfree CJ, McCormick PC, Cruz M, Stein BM, Antonescu R. Intramedullary spinal cord metastasis: report of three cases and review of the literature. Surg Neurol. 1996; 46 (4): 329-338. doi:10.1016/S0090-3019(96)00189-2.




Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Columna. 2026;4